Characteristics of B-ultrasonic Renal Changes in Chronic Aristolochic Acid Nephropathy

ZHOU Yong-hong,YANG Li,QIN Wei,QU Hai-yun,LI Xiao-mei
DOI: https://doi.org/10.3760/j.issn:1001-7097.2006.07.004
2005-01-01
Abstract:Objective To observe the B- ultrasonic (B-US) renal changes of chronic aristolochic acid nephropathy (CAAN) patients and to determine its value in disease diagnosis. Methods The renal B-US data of 124 CAAN patients were retrospectively studied. The relationship between the B-US characteristics and the renal function was tested. Clinicopathological data of 19 CAAN patients underwent renal biopsy were compared with those of 18 patients with chronic tubulointerstitial nephropathy due to none-aristolochic acid causes (non-AAN-CTIN). Results The characteristics of renal B-US changes in CAAN patients included diminished parenchyma thickness (90.3%), atrophy of the kidney (62.90%) and asymmetrically shrinked kidneys (17.74%). The renal B-US markers, including the longitude, the volume and the parenchyma thickness, were closely associated with the level of Scr, eGFR and the function of renal tubules (P 0.05). There was no difference in the severity of impairment of renal function between the CAAN-renal biopsy group and the non-AAN-CTIN group. Histological studies showed that the CAAN-renal biopsy group exhibited more severe tubular epithelial exfoliation and glomerular ischemic shrinkage, while the immune cells infiltrating was much less obvious as compared to the non-AAN-CTIN group (P 0.05). However, the size of the kidney diminished and the parenchyma was thickened more markedly in the CAAN group as compared to those of non-AAN-CTIN (P0.05). Conclusions The CAAN patients exhibit the B-US manifestations including kidney shrink, thinning of renal parenchyma and asymmetrically atrophy of the two kidneys, among which the parenchyma thickness was the earliest abnormal index. Compared with the CTIN patients of the other causes, the CAAN patients showed earlier and more significant kidney atrophy. The B-US examination of CAAN patients can be used as an assisted assessing index of clinical impairment of renal function.
What problem does this paper attempt to address?